1. 500 Pembrolizumab (MK-3475) for PD-L1-positive squamous cell carcinoma (SCC) of the anal canal: Preliminary safety and efficacy results from KEYNOTE-028. Issue 3 (September 2015) Authors: Ott, P.A.; Piha-Paul, S.A.; Munster, P.; Pishvaian, M.J.; Van Brummelen, E.; Cohen, R.; Gomez-Roca, C.; Ejadi, S.; Stein, M.; Chan, E.; Simonelli, M.; Morosky, A.; Yuan, S.S.; Koshiji, M.; Bennouna, J. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 502 Pembrolizumab (MK-3475) for patients (pts) with advanced colorectal carcinoma (CRC): Preliminary results from KEYNOTE-028. (September 2015) Authors: O'Neil, B.H.; Wallmark, J.; Lorente, D.; Elez, E.; Raimbourg, J.; Gomez-Roca, C.; Ejadi, S.; Piha-Paul, S.A.; Moss, R.A.; Siu, L.L.; Dotti, K.; Santoro, A.; Gould, M.; Yuan, S.S.; Koshiji, M.; Han, S.W. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours. (August 2017) Authors: Hollebecque, A.; Bahleda, R.; Faivre, L.; Adam, J.; Poinsignon, V.; Paci, A.; Gomez-Roca, C.; Thery, J.C.; Le Deley, M.C.; Varga, A.; Gazzah, A.; Ileana, E.; Gharib, M.; Angevin, E.; Malekzadeh, K.; Massard, C.; Soria, J.C.; Spano, J.P. Journal: European journal of cancer Issue: Volume 81(2017) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗